ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $379,246 | -44.4% | 14,592 | -38.8% | 0.05% | -39.1% |
| Q1 2024 | $681,767 | +79.3% | 23,838 | +91.8% | 0.09% | +17.6% |
| Q4 2023 | $380,327 | +414.1% | 12,429 | +351.5% | 0.07% | +252.4% |
| Q3 2023 | $73,973 | +48.1% | 2,753 | +96.5% | 0.02% | +40.0% |
| Q2 2023 | $49,960 | +34.1% | 1,401 | -4.5% | 0.02% | +15.4% |
| Q1 2023 | $37,262 | -14.7% | 1,467 | +36.2% | 0.01% | -27.8% |
| Q4 2022 | $43,683 | +32.4% | 1,077 | +8.6% | 0.02% | +28.6% |
| Q3 2022 | $33,000 | – | 992 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $93,815,000 | 51.06% |
| Aquilo Capital Management, LLC | 436,514 | $12,559,000 | 4.90% |
| Vivo Capital, LLC | 768,674 | $22,115,000 | 2.00% |
| ACUTA CAPITAL PARTNERS, LLC | 109,700 | $3,156,000 | 1.53% |
| Prosight Management, LP | 104,737 | $3,013,000 | 1.41% |
| Capital Impact Advisors, LLC | 84,537 | $2,432,000 | 1.02% |
| Artal Group S.A. | 600,000 | $17,262,000 | 0.73% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 62,000 | $1,784,000 | 0.48% |
| Quantitative Investment Management, LLC | 150,401 | $4,327,000 | 0.47% |
| OAK RIDGE INVESTMENTS LLC | 131,502 | $3,784,000 | 0.39% |